Pancreatic Neoplasms: all 3,310 studies

Page 33 of 34. Open to participants first (910), then studies with results posted, then the rest; newest registration first within each.

• UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00045747Phase 2
• Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic CarcinomaCompletedNCT00044031Phase 3
• Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the LiverCompletedNCT00041808Phase 1/2
• Safety Study of 90Y-hMN14 to Treat Pancreatic CancerCompletedNCT00041639Phase 1/2
• Acupuncture and Acupressure in Treating Patients With Moderate or Severe Pain Related to Stage III or Stage IV Pancreatic CancerCompletedNCT00040833Phase 2
• OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.CompletedNCT00040183Phase 3
• A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic CancerCompletedNCT00040092Phase 3
• UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic CancerCompletedNCT00039403Phase 1
• Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of PancreasTerminatedNCT00038701Phase 2
• A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.CompletedNCT00035035Phase 3
• A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic CancerCompletedNCT00034827Phase 2
• Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2CompletedNCT00034281Phase 1
• Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic CancerCompletedNCT00033735Phase 3
• CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung CancerCompletedNCT00033384Phase 2
• Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid TumorsCompletedNCT00033241Phase 1
• Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00032175Phase 3
• Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic CancerTerminatedNCT00031837Phase 3
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
• Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic CancerCompletedNCT00030732Phase 3
• Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
• Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic CancerCompletedNCT00028834Phase 2
• Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerCompletedNCT00028496Phase 1
• Vaccine Therapy in Treating Patients With Advanced or Metastatic CancerCompletedNCT00027534Phase 1
• Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic CancerWithdrawnNCT00027521Phase 1
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic CancerCompletedNCT00026403Phase 2
• Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic CancerCompletedNCT00026338Phase 3
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic CancerCompletedNCT00026130Phase 2
• Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic CancerCompletedNCT00026104Phase 2
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal CancerWithdrawnNCT00025532Phase 1
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic CancerCompletedNCT00025168Phase 2
• Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic CancerCompletedNCT00024427Phase 3
• DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic CancerStatus unknownNCT00024375Phase 2
• BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With SurgeryStatus unknownNCT00024362Phase 2
• SU006668 in Treating Patients With Advanced Solid TumorsStatus unknownNCT00024063Phase 1
• Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00023972Phase 3
• Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the PancreasCompletedNCT00020345Phase 2
• Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasCompletedNCT00019513Phase 1
• Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract CancerCompletedNCT00019474Phase 2
• LMB-9 Immunotoxin in Treating Patients With Advanced Solid TumorsCompletedNCT00019435Phase 1
• Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsCompletedNCT00019331Phase 2
• Vaccine Therapy and Biological Therapy in Treating Patients With Advanced CancerCompletedNCT00019084Phase 2
• Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung CancerCompletedNCT00019006Phase 1
• BMS-247550 in Treating Patients With Advanced Pancreatic CancerCompletedNCT00016965Phase 2
• Vapreotide in Treating Patients Undergoing Elective Pancreatic ResectionTerminatedNCT00014651Phase 3
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsCompletedNCT00014456Phase 1
• Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal TractTerminatedNCT00012246Phase 2
• Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the PancreasCompletedNCT00012220Phase 2
• LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal CancerStatus unknownNCT00010270Phase 1
• Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the PancreasCompletedNCT00010166Phase 2
• Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile DuctStatus unknownNCT00010088Phase 2
• Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic CancerStatus unknownNCT00010062Phase 2
• Vaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic CancerCompletedNCT00008099Phase 1
• Immunotoxin Therapy in Treating Patients With Advanced CancerCompletedNCT00006981Phase 1
• Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the PancreasCompletedNCT00006467Phase 2
• Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal CancerCompletedNCT00006387Phase 1
• Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerStatus unknownNCT00006117Phase 2
• Gemcitabine, Herceptin and Radiation to Treat Cancer of the PancreasCompletedNCT00005926Phase 2
• Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic CancerStatus unknownNCT00005871Phase 3
• Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the PancreasStatus unknownNCT00005870Phase 3
• Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic CancerStatus unknownNCT00005869Phase 3
• LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian CancerCompletedNCT00005858Phase 1
• R115777 in Treating Patients Who Have Metastatic Pancreatic CancerCompletedNCT00005843Phase 2
• S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00005832Phase 2
• Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic CancerCompletedNCT00005648Phase 3
• ISIS 2503 in Treating Patients With Advanced Cancer of the PancreasCompletedNCT00005594Phase 2
• Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the PancreasWithdrawnNCT00005591Phase 2
• Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic CancerCompletedNCT00005053Phase 2
• Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal ObstructionCompletedNCT00004910Phase 1/2
• Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by SurgeryCompletedNCT00004895Phase 2
• Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic CancerCompletedNCT00004884Phase 2
• Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction CancerCompletedNCT00004879Phase 1
• Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic CancerCompletedNCT00004861Phase 2
• Biological Therapy in Treating Patients With Metastatic CancerCompletedNCT00004604Phase 1
• Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00004190Phase 2
• Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00004095Phase 1
• Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic CancerCompletedNCT00004087Phase 1/2
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT00004003Phase 2
• DX-8951f in Treating Patients With Metastatic Cancer of the PancreasCompletedNCT00003951Phase 2
• Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or PancreasCompletedNCT00003923Phase 2
• Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic CancerTerminatedNCT00003851Not applicable
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the PancreasCompletedNCT00003810Phase 2
• Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by SurgeryCompletedNCT00003798Phase 1
• Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the PancreasStatus unknownNCT00003797Phase 2
• Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the PancreasStatus unknownNCT00003780Phase 2
• Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic CancerCompletedNCT00003769Phase 2
• Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic CancerCompletedNCT00003760Phase 2
• Dolastatin 10 in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00003677Phase 2
• Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic CancerCompletedNCT00003591Phase 2
• Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic CancerCompletedNCT00003546Phase 2
• Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic CancerTerminatedNCT00003434Phase 1
• Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal CancerCompletedNCT00003427Phase 1
• Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic CancerCompletedNCT00003426Phase 1
• Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic CancerCompletedNCT00003411Phase 1
• Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic CancerCompletedNCT00003332Phase 1/2
• Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the PancreasCompletedNCT00003216Phase 3
• Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or StomachCompletedNCT00003157Phase 1
• Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced TumorsCompletedNCT00003125Phase 2
• Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic CancerTerminatedNCT00003085Phase 2
• Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the PancreasCompletedNCT00003049Phase 3

← Pancreatic Neoplasms overview